From Regeneration Failure to Functional Restoration: Unlocking the Neuronal‐Intrinsic Regenerative Capacity as a Therapeutic Frontier for Optic Neuropathy and Glaucoma

This review explores how intrinsic growth barriers and inadequate activation of pro-regenerative genes impede axonal regrowth following injury, and how manipulations of these pathways facilitate axon regeneration and visual recovery in experimental models. Emerging findings suggest that these pro-regenerative molecules capable of modifying the neuronal-intrinsic regenerative capacity of RGCs can also preserve visual function in pre-clinical glaucoma models. Finally, we discuss challenges and future directions for translating these findings into therapies, including gene delivery strategies, remyelination therapeutics, and systems biology-based in silico drug screening approaches aiming to reshape the therapeutic landscape towards regenerative interventions for glaucomatous and other optic neuropathies.

Authors

Institutions

Publication Details

Journal
CNS Neuroscience & Therapeutics
Published
2026-02-01
DOI
https://doi.org/10.1002/cns.70800
Primary Topic
Nerve injury and regeneration
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

From Regeneration Failure to Functional Restoration: Unlocking the Neuronal‐Intrinsic Regenerative Capacity as a Therapeutic Frontier for Optic Neuropathy and Glaucoma

Yujiao Jennifer Sun, Zahra Kader, Ngan Pan Bennett Au, Safa El‐Bushra et al.
CNS Neuroscience & Therapeutics
Nerve injury and regeneration
article

From Regeneration Failure to Functional Restoration: Unlocking the Neuronal‐Intrinsic Regenerative Capacity as a Therapeutic Frontier for Optic Neuropathy and Glaucoma

Yujiao Jennifer Sun, Zahra Kader, Ngan Pan Bennett Au, Safa El‐Bushra, Emma Beard
article en

Abstract

This review explores how intrinsic growth barriers and inadequate activation of pro-regenerative genes impede axonal regrowth following injury, and how manipulations of these pathways facilitate axon regeneration and visual recovery in experimental models. Emerging findings suggest that these pro-regenerative molecules capable of modifying the neuronal-intrinsic regenerative capacity of RGCs can also preserve visual function in pre-clinical glaucoma models. Finally, we discuss challenges and future directions for translating these findings into therapies, including gene delivery strategies, remyelination therapeutics, and systems biology-based in silico drug screening approaches aiming to reshape the therapeutic landscape towards regenerative interventions for glaucomatous and other optic neuropathies.

CNS Neuroscience & TherapeuticsVol. 32(2)
University of Surrey (GB), University College London (GB), University of Portsmouth (GB)
Sight Research UK, Rosetrees Trust, Ministerio de Economía y Competitividad, Moorfields Eye Charity, National Institutes of Health, National Institute of Allergy and Infectious Diseases
Openalex Percentile: Top 48%
Nerve injury and regeneration
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

From Regeneration Failure to Functional Restoration: Unlocking the Neuronal‐Intrinsic Regenerative Capacity as a Therapeutic Frontier for Optic Neuropathy and Glaucoma — Yujiao Jennifer Sun, Zahra Kader, et al. · CNS Neuroscience & Therapeutics (2026) | TGRS Research Map | TGRS